dc.date.accessioned2019-01-25T15:28:04Z
dc.date.available2019-01-25T15:28:04Z
dc.date.created2019-01-25T15:28:04Z
dc.date.issued2017
dc.identifierhttps://hdl.handle.net/20.500.12866/4685
dc.identifierhttps://doi.org/10.4269/ajtmh.16-0804
dc.description.abstractIntestinal infection caused by Cryptosporidium is a major contributor to diarrhea morbidity and mortality in young children around the world. Current treatments for children suffering from cryptosporidiosis are suboptimal. Lactoferrin is a glycoprotein found in breast milk. It has showed bacteriostatic and antimicrobial activity in the intestine. However, the effects of lactoferrin on the intestinal parasite Cryptosporidium have not been reported. In this study, we investigated the anticryptosporidial activity of human lactoferrin on different stages of Cryptosporidium. Physiologic concentrations of lactoferrin killed Cryptosporidium parvum sporozoites, but had no significant effect on oocysts viability or parasite intracellular development. Since sporozoites are essential for the infection process, our data reinforce the importance of breastfeeding and point to the potential of lactoferrin as a novel therapeutic agent for cryptosporidiosis.
dc.languageeng
dc.publisherAmerican Society of Tropical Medicine and Hygiene
dc.relationAmerican Journal of Tropical Medicine and Hygiene (ASTMH Journal)
dc.relation1476-1645
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectCryptosporidium/drug effects
dc.subjectHumans
dc.subjectLactoferrin/chemistry/pharmacology
dc.subjectMilk, Human/chemistry
dc.subjectOocysts/drug effects
dc.subjectSporozoites/drug effects
dc.titleKilling of Cryptosporidium sporozoites by Lactoferrin
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución